RCM Technologies (RCMT) Stock Forecast & Price Target

RCM Technologies is viewed positively because it delivered 2Q26 revenue of $93.8M, up 20.2% year over year, alongside adjusted EBITDA of $9.3M, adjusted EPS of $0.82, and operating cash flow of $13.5M, underscoring both growth and cash generation. Its Specialty Health Care segment remains the most consistent earnings driver, while Engineering and Life Sciences, Data and Solutions showed strong revenue gains of 49.0% and 8.4%, supported by backlog, pipeline strength, and improving demand tied to energy utilities and data center development. Even with some margin variability from project mix, the asset-light model, high-margin service lines, and discounted valuation versus peers support the outlook, especially as operating cash flow increased by over 54% in 1H26.

RCM Technologies is exposed to multiple fundamental weaknesses that support a negative outlook, including acquisition integration risk, possible financing strain from future M&A, and intense competition from larger peers with greater resources. Its revenue base is concentrated in North America and sensitive to economic cycles, cyclical end markets such as engineering and construction, and labor availability, which can pressure growth and margins if demand softens or talent retention weakens. The company also faces regulatory and client concentration risk, with the New York City Board of Education representing 10.6% of revenues in 2020 and its top five customers accounting for 33.4% of revenues, while limited stock liquidity adds another layer of risk.